Skip to main content
news

News from our members

On this page, you will find the latest news from the cluster's members!

• 29/07/20 - UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer’s Disease

ucb

UCB will receive an initial upfront payment and, after positive completion of proof-of-concept in Alzheimer’s Disease, is eligible to receive further potential payments with a total potential consideration approaching US $2 billion upon receipt of certain regulatory approvals and satisfying certain milestones. Read more

• 24/07/20 - L'Awex poursuit son évangélisation vers l'international (Only available in french)

awex

En ces temps de crise, l'agence wallonne à l'exportation a adapté sa stratégie afin de soutenir les entreprises dans leurs prospections à l'international. Read more

• 24/07/20 - Vésale Pharma se lance dans l'e-commerce et signe un contrat de plus de 8 millions d'euros (Only available in french)

logo

La société wallonne Vésale Pharma, spécialisée dans la recherche et le développement de solutions innovantes à base de probiotiques, poursuit son expansion sur le continent asiatique. Read more

• 24/07/20 - La biotech belge iTeos se lance aujourd'hui sur le Nasdaq. (Only available in french)

iteos

La biotech wallonne iTeos sera cotée ce vendredi sur le Nasdaq sous le symbole "ITOS". Son cours d'introduction a été fixé à 19 dollars, soit au-delà de la fourchette précédemment annoncée. Read more

• 14/07/20 - Thomas Lienard, président de la medtech Antigon. (Only available in french)

Antigon

L’ancien CEO de Bone Therapeutics préside depuis début juillet le conseil d’administration d’Antigon, une jeune spin-off de l’ULB spécialisée dans la sécurisation des transfusions sanguines. Read more

• 14/07/20 - Celyad Oncology Announces FDA Clearance of IND Application for CYAD-211, First shRNA-based, Non-Gene Edited Allogeneic CAR T Therapy 

Celyad

Celyad Oncology today announced that  the company’s Investigational New Drug (IND) application for CYAD-211, the company’s first-in-class short hairpin RNA (shRNA)-based allogeneic CAR T candidate and second non-gene edited off-the-shelf program, is in effect with the U.S. Food and Drug Administration (FDA). Read more

• 10/07/20 - Universities and Covid-19: Inventiveness and goodwill at the service of society

UNamur

During the Covid-19 crisis, universities innovated greatly in various fields to bring solutions to complex and unprecedented challenges. This article by Annick Castiaux analyses an innovation project led by the University of Namur in Belgium, providing evidence of the particularities of innovation in times of crisis and the societal role of universities. Read more

• 09/07/20 - OncoDNA va reprendre la société française IntegraGen.(Only available in french)

OncoDNA

La biotech wallonne a conclu un accord en vue d'une offre publique d’achat amicale sur la société française IntegraGen, spécialisée dans le séquençage d'ADN. Read more

• 08/07/20 - Kaneka Eurogentec receives GMP accreditation for its new state-of-the-art facility in time for the production of DNA vaccines against COVID-19

Eurogentec

The new state-of-the-art facility allows the large-scale production of new generation of medicines. Read more

• 07/07/20 - Un détecteur de Covid-19 quasiment infaillible. (Only available in french)

D-tek

La société montoise D-tek s'apprête à lancer un test de diagnostic du Covid-19 basé sur la détection de 5 biomarqueurs. Sa fiabilité dépasse les 95%. Read more

• 06/07/20 - Mithra Signs LSA for Commercialization of Myring™ in France, Poland and United Kingdom

Mithra

Mithra announces that it has entered into a license and supply agreement (LSA)
with Zentiva for the commercialization of its hormonal contraceptive ring Myring™ in France, Poland and the United Kingdom. Read more

• 02/07/20 - Le BioPark de Charleroi/Bruxelles-Sud se prépare à engager plusieurs centaines de personnes dans les mois à venir. (Only available in french)

logos

Univercells, Novadip, MaSTherCells et Delphi Genetics recrutent des dizaines de profils chacun. Plusieurs centaines d'emplois seront à pourvoir dans les semaines et mois à venir dans le BioPark de Gosselies (Charleroi), lequel regroupe plus de 80 entreprises et centres de recherche dans les domaines de la biotechnologie et de la biopharmacie, a-t-il annoncé jeudi dans un communiqué. L'épidémie de Covid-19 n'est pas tout à fait étrangère à ces créations d'emplois. Read more

• 30/06/20 - Hyloris a fait ses premiers pas sur Euronext Bruxelles. (Only available in french)

Hyloris

L'action du groupe biopharma a démarré à un cours de 10,75 euros. Soit à son prix établi à l'issue de son IPO. Read more

• 26/06/20 - Hyloris s'apprête à sonner la cloche d'Euronext Bruxelles. (Only available in french)

Hyloris

La société pharmaceutique arrive sur Euronext Bruxelles dès lundi prochain. Cela, au terme d’une offre publique qui s’est achevée ce jeudi pour les investisseurs particuliers. Read more

• 25/06/20 - PDC*line Pharma accueille le Dr Mondher Mahjoubi en tant que président de son conseil d'administration

PDC line

PDC*line Pharma renforce son conseil d'administration avec un leader de l’industrie dans le domaine de l'immuno-oncologie. Read more

• 25/06/20 - La biotech wallonne iTeos Therapeutics va faire son entrée sur le Nasdaq. (Only available in french)

iteos

Après une levée de fonds record il y a moins de trois mois, la biotech wallonne annonce son introduction prochaine sur le Nasdaq américain. Une consécration pour cette entreprise du Biopark de Gosselies, spécialisée dans les traitements par immunothérapie contre le cancer. Read more

• 25/06/20 - La pépite wallonne Nyxoah prépare son arrivée sur le marché américain. (Only available in french)

Nyxoah

La société de technologie médicale a reçu le feu vert de la FDA pour lancer une étude d'évaluation aux USA pour son dispositif destiné à traiter les troubles respiratoires du sommeil. Une nouvelle levée de fonds est en préparation. Read more

• 23/06/20 - La liégeoise Miracor à 15 mois de commercialiser son dispositif anti-infarctus (Only available in french)

Miracor

Miracor a obtenu le marquage CE pour la nouvelle version de son dispositif permettant de traiter les patients ayant souffert d’un infarctus aigu. Une nouvelle levée de fonds est en préparation. Read more

• 23/06/20 - Antibiorésistance : le système de défense des bactéries enfin percé à jour ? (Only available in french)

UCLouvain

L'antibiorésistance - la capacité de certaines bactéries à résister aux médicaments - constitue l'une des plus grandes menaces pesant sur la santé mondiale. Des chercheurs belges de l'UCLouvain ont aujourd'hui réussi à capter des images inédites de ce système de défense. Une découverte importante qui devrait permettre la production de nouveaux antibiotiques plus performants. Read more

• 18/06/20 - Mithra Successfully Raises EUR 65 Million By Means of a Private Placement via an Accelerated Bookbuild Offering

Mithra

Mithra  announces today that it successfully raised an amount of EUR 65.0 million in gross proceeds by means of a private placement via an accelerated bookbuild offering of 3,421,052 new shares (being approximately 8.74% of the Company’s outstanding shares) at an issue price of EUR 19.00 per share (the “Private Placement“). Read more

• 17/06/20 - 9 best healthcare and medical startups in Belgium in 2020 (Silicon Canals): Promethera Biosciences and Novadip

Promethera

Novadip


 

As Belgian health tech is doing pretty well over the years with several notable investments and innovative approaches, we at Silicon Canals have curated a list of fast-growing startups. Read more

• 17/06/20 - Hyloris donne le coup d'envoi de son IPO (Only available in french)

Hyloris

La biopharma liégeoise offre en souscription, à partir de ce mercredi, 5 millions d'actions nouvelles dans une fourchette de prix comprise entre 10 euros et 11,5 euros. Read more

• 16/06/20 - Auxin Surgery séduit de plus en plus de chirurgiens dans le monde (Only available in french)

Auxin

Le dispositif médical développé par la société de Louvain-La-Neuve intéresse un nombre croissant de pays et voit ses indications se multiplier. Yves Prete a fait son entrée dans le conseil d'administration. Read more

• 15/06/20 - Novasep partners with AstraZeneca to produce covid-19 Oxford vaccine for Europe

Novasep

Novasep, a French company and European leader in the production of viral vectors, announces that it has signed a partnership with the biopharmaceutical company AstraZeneca for the production of the Oxford University vaccine to prevent COVID-19 infection. Read more

• 15/06/20 - Lamarche et Debruyne montent à bord de Fund+ (Only available in french)

Fund+

L'ex-co-administrateur délégué de GBL et l'ancien numéro un de la division vaccins de GSK viennent guider le plus important fonds d'investissement belge en biotechs. Read more

• 12/06/20 -  A step forward for UCB with its psoriasis treatment.

ucb

First Presentations of Bimekizumab Phase 3 Data Demonstrate Superior Skin Clearance Over Placebo and Stelara[®] at Week 16 in Adults with Moderate-to-Severe Plaque Psoriasis. Read more

• 11/06/20 -  Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020

BT

Shareholders approved all resolutions. Read more

• 11/06/20 -  Mithra Signs LSA for Commercialization of Tibelia® in Liechtenstein and Switzerland

Mithra

Mithra grants license to Spirig Healthcare (Stada Group) for commercialization of its hormone treatment Tibelia® in Liechtenstein and Switzerland. Tibelia® is currently marketed in about 30 countries through existing license and supply agreements. Read more

• 10/06/20 -  Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

J&J

Johnson & Johnson today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020. Read more

• 10/06/20 -  Celyad Rebrands as Celyad Oncology

Celyad

Celyad SA (Euronext & Nasdaq: CYAD) today announced the launch of its corporate rebranding, including changing its name to Celyad Oncology. The new name highlights the Company’s significant progress with its next-generation CAR T programs and emphasizes its commitment to cancer patients.

• 05/06/20 -  UCB acquiert une biopharma américaine (Only available in french)

ucb

UCB achète Engage Therapeutics, une biopharma qui développe un inhalateur pour le traitement des crises d'épilepsie. Le montant de ce rachat pourra atteindre un maximum de 270 millions de dollars. Read More

• 05/06/20 -  Mithra Issues First Put Option Notice Under Capital Agreement with LDA Capital

Mithra

Mithra Pharmaceuticals SA today announces that following the signature of the capital commitment agreement with LDA Capital Limited announced on April 24, 2020 , the Board of Directors approved on May 22, 2020 an increase to the Company’s capital by means of an issuance of new ordinary shares through authorized capital. The first put option notice was issued last Friday, May 29, 2020, according to the terms of the capital commitment agreement. Read more

• 03/06/20 - Hyloris Pharma prépare son introduction sur Euronext Bruxelles  (Only available in french)

hyloris

La biotech liégeoise créée par Stijn Van Rompay vient de dévoiler son intention de se faire coter sur Euronext Bruxelles. Une opération qui devrait être finalisée début juillet. Read more

• 01/06/20 - Celyad Provides Update on Allogeneic CAR-T Franchise including CYAD-101 and shRNA Platform at the 2020 ASCO Virtual Scientific Program

logo

Celyad today announced updates from the company’s allogeneic programs, including additional data from the Phase 1 alloSHRINK trial evaluating the T cell receptor (TCR) inhibitory molecule (TIM)-based, non-gene edited allogeneic CAR-T candidate, CYAD‑101, for the treatment of metastatic colorectal cancer (mCRC), and the company’s short hairpin RNA (shRNA) platform underpinning the next-generation, non-gene edited CYAD-200 series of CAR-T candidates. Read more

• 28/05/20 - GSK va produire un milliard de doses d'adjuvants pour les vaccins Covid-19

GSK

Le géant pharmaceutique britannique a indiqué qu'il entendait produire un milliard de doses d'adjuvants pour les vaccins Covid-19 en 2021. La fabrication aura lieu sur des sites en Europe et en Amérique du Nord. Read more

• 28/05/20 - Mithra Signs License and Supply Agreement with Mayne Pharma for Commercialization of Estelle in Australia

Mithra

Mithra today announces it has entered into an exclusive 20-year license and supply agreement with Mayne Pharma Group Limited (“Mayne”) for the commercialization of its combined oral contraceptive E4/DRSP (Estelle) in Australia. Read more

• 28/05/20 - Oncodesign establishes strategic alliance with HitGen to strengthen its integrated drug discovery service

Oncodesign

Oncodesign announces that it has formed a new strategic alliance with HitGen, a Chinese biotech company. This partnership complements Oncodesign’s technological platforms and enables the identification of novel hits for challenging biological targets. It also strengthens its Integrated Drug Discovery Service (IDDS) offer, known as DRIVE™ (DRug Integrative discoVEry). Read more

• 25/05/20 - NOVASEP and LYSOGENE Announce their New Collaboration for Development and Production of GM1 Gangliosidosis Gene Therapy Product

Novasep

With this collaboration, the two companies consolidate their long-lasting partnership initiated with the development and manufacturing of Lysogene’s lead gene therapy product, LYS-SAF302, currently in clinical phase 2/3. Read more

• 25/05/20 - Mithra Launches a Research Programme on Estetrol's Effect in Covid-19 Treatment. 

Mithra

Mithra today announces its intention to launch a Phase II study program to assess the potential beneficial effect of Estetrol (E4) on Covid-19 infection. E4 is a naturally occurring estrogen produced by the liver of the human fetus, passing in maternal blood at relatively high levels during pregnancy. Read more

• 20/05/20 - Mithra and Searchlight Pharma Announce Filing of New Drug Submission for Estelle® in Canada

Mithra

Mithra and Searchlight Pharma announced today that Health Canada has accepted Searchlight Pharma’s New Drug Submission (“NDS”) for a novel combined oral contraceptive (COC) product. Read more

• 18/05/20 - Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study

logo

BONE THERAPEUTICS today announces it has commenced treating the first patients for the pivotal JTA-004 phase III clinical study in Hong Kong SAR. Read more

• 18/05/20 - Miracor Medical - Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study

logo miracor

The aim of this clinical research was to investigate the effects of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size at 5 days after primary percutaneous coronary intervention (pPCI) in patients with ST-segment elevation myocardial infarction (STEMI). Read more

• 18/05/20 - The Walloon government has labeled NeuroPath’s R&I project. NeuroInsights joins a portfolio of 49 R&I projects

logo

NeuroInsights provides a Digital Health Platform to connect the daily living of the patient with the interdisciplinary team of care providers and clinicians. Read more

• 14/05/20 - Exyte & Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic

Univercells

The combined offer will enable users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to new disease outbreaks. Read more

• 14/05/20 - Une première mondiale chirurgicale avec des implants en os synthétique développés à Liège

Cerhum3D side

C’est une technologie développée par la PME liégeoise Cerhum avec l’expertise de 3DSide qui a permis de concevoir cet implant inédit. Read more

• 12/05/20 - IMI announces COVID projects, boosts funding pot to EUR 72 million. The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. One of the projects, Dragon (Rapid and secure AI imaging based diagnosis, stratification, follow-up, and preparedness for coronavirus pandemics) will be lead by Oncoradiomics

Oncoradiomics

The DRAGON project will apply artificial intelligence and machine learning to deliver a decision support system for improved and more rapid diagnosis and prognosis. Citizens and patients will be involved in the development of the system. Read more

• 13/05/20 - Résultats encourageants pour Novadip dans la reconstruction osseuse

Novadip

Plusieurs patients suivis par la biotech wallonne dans la cadre d'une étude clinique exploratoire évoluent vers une régénération osseuse complète six mois seulement après avoir été implantés. Read more

• 07/05/20 - Bone Therapeutics raises additional EUR 4.0 million, with total of EUR 15.0 million committed, providing runway into Q2 2021

logo

The company today announces that it has received EUR 4.0 million. This enables Bone Therapeutics’ bond investors to be repaid in the company’s shares, with a conversion price of EUR 7.0 per share. This additional EUR 4.0 million financing has been achieved a week after the EUR 11.0 million financing round. Read more

• 07/05/20 - Celyad Announces First Quarter 2020 Financial Results and Recent Business Highlights

logo

Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced an update on operational developments for the first quarter ended March 31, 2020. Read more

• 06/05/20 - Celyad Appoints Seasoned Industry Executives to Board of Directors

logo

Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that Dr. Maria Koehler and Mr. Dominic Piscitelli have been appointed as independent members to its Board of Directors, effective as of March 24 and May 6, respectively. Read more

• 05/05/20 -  Launch of Univercells Technologies for intensified, automated technologies 

logo

Univercells Technologies, a global provider of next-generation bioprocess technologies, launches today.  Under this new brand, the company will focus on the commercialization of the product portfolio and will explore new technology developments to expand its position in the cell and gene therapy market. Read More

• 05/05/20 - Mithra and Gynial Sign Commercialization Agreement for Myring™ in Switzerland

Mithra

Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that it has entered into a license and supply agreement (LSA) with Gynial GmbH for the commercialization of its hormonal contraceptive ring Myring™ in Switzerland. Read more

• 30/04/20 - La biotech Hyloris attire de nouveaux investisseurs flamands (Only available in french)

logo

La biotech liégeoise Hyloris a levé 15 millions d'euros pour développer ses médicaments reformulés. En savoir plus

• 30/04/20 - IRE supplies a first commercial batch of LEU-based Mo-99

logo

The Institute for radioelements (IRE), one of the leaders in the production of Molybdenum-99 (Mo-99), the most widely used radio-isotope in nuclear medicine for diagnosis, announced today that the company produced its first commercial Mo-99 Low Enriched Uranium (LEU) batch for the US market. Read more

• 29/04/20 - Bone Therapeutics secures EUR 11.0 million financing

logo

Bone Therapeutics today announces that it secured EUR 11.0 million financing. The financing will be used to advance both of its key assets, ALLOB and JTA-004, through late stage clinical development. Read more

• 28/04/20 - Coronavirus en Belgique: Univercells se prépare à produire un vaccin (Only available in french)

logo

Un vaccin contre le coronavirus Covid-19 est attendu avec grande impatience. L'entreprise de Nivelles, Univercells, se prépare d'ailleurs à produire ce vaccin grâce à un système de conteneurs. En savoir plus

• 28/04/20 - Les tests rapides du liégeois ZenTech validés par l'agence fédérale des médicaments (Only available in french)

zentech

Les tests de dépistage du Covid-19 de la société liégeoise ZenTech viennent d’obtenir la certification de l’agence fédérale des médicaments (AFPMS). Ils peuvent donc désormais être commercialisés en Belgique. En savoir plus

• 27/04/20 - Brussels South Charleroi BioPark announces strong Q1 2020 performance

logo

Despite the Coronavirus crisis, Brussels South Charleroi BioPark, which gathers 70+ biotech and biopharma players, booked a historically strong performance in the first quarter of 2020. Read more

• 24/04/20 - BioCair transports COVID-19 related protective equipment

logo

Biocair has recently managed several urgent large-scale shipments of COVID-19 related protective equipment. The specialist logistics company is also supporting many companies and agencies with the swift transportation of testing kits, diagnostic specimens and medical devices. Read more

• 24/04/20 - Mithra Obtains a Capital Commitment Agreement of EUR 50 Million from Partner LDA Capital

Mithra

Mithra today announces that it has entered into a capital commitment agreement with LDA Capital Limited, a Los Angeles based global investment group with expertise in cross border transactions in life science sector. Read more

• 23/04/20 - ReiThera, Leukocare and Univercells announce fast-track development of a COVID-19 vaccine

logo

The vaccine candidate is expected to enter clinical trials during summer 2020 with large-scale vaccine production planned to start soon after. Read more

• 23/04/20 - Solution SalamanderU et solidfog technologies pour la décontamination de masques ffp2 (Only available in french)

logo

Les deux entreprises ont collaboré pour fournir une solution opérationnelle simple et robuste pour la décontamination de masques FFP2 en grande quantité et à installer directement au sein du milieu hospitalier. En savoir plus / Infographie

• 21/04/20 - Le spécialiste wallon de l'hygiène Realco/OneLife tourne à nouveau à plein régime. (Only available in french)

OneLIfe


Le site de Louvain-La-Neuve de Realco avait été en partie détruit par un incendie début janvier. L’entreprise de Louvain-La-Neuve estime avoir des solutions à proposer pour le déconfinement. En savoir plus

• 17/04/20 - Walloon company ZenTech launches its production of serological tests (Only available in french)

zentech


Liège-based bio-tech company ZenTech launched its own production line for rapid screening tests for Covid-19 on Thursday morning. These serological tests detect antibodies that appear after a coronavirus infection. Read more

• 16/04/20 - Mayne Pharma Submits New Drug Application For E4/DRSP to the FDA

Mithra

Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) today announced that Mayne Pharma has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA), seeking marketing authorisation for E4/DRSP, a combined oral contraceptive indicated for the prevention of pregnancy in women. Read more

• 14/04/20 - GSK et Sanofi s'unissent pour développer un vaccin qui aura des accents belges (Only available in french)

logo

Les deux géants pharmaceutiques GSK et Sanofi espèrent lancer les essais cliniques au second semestre 2020 pour commercialiser un vaccin contre le Covid-19 un an plus tard. Le site belge de Rixensart de GSK sera impliqué dans les recherches notamment via sa technologie des adjuvants. Read more

• 08/04/20 - Orgenesis Announces Joint Venture Agreement with RevaTis 

revatis

The goal of the JV is to advance the development of autologous therapies, including in-licensed therapies through Orgenesis’s partners, utilizing and banking muscle-derived mesenchymal stem cells (mdMSC) as a source of exosomes and other cellular products. Read more

• 02/04/20 - Mithra Announces Commercial Launch of Myring™ in Germany, the biggest market in Europe.

Mithra

Mithra, a company dedicated to Women’s Health announced the commercial launch of Myring™ in Germany, which is the largest European market and the second worldwide in terms of sales volume. Read more

• 01/04/20 - iTeos Therapeutics closes $125 Million Series B2 Financing!

iteos

iTeos Therapeutics, biotech company in our Walloon ecosystem, raised $125 million to support the clinical development of its two innovative cancer immunotherapy programs. Read more

You have news to share? Contact us!